Systemic lupus erythematosus (SLE) occurs when the immune system, which normally fights infections and bacteria, starts attacking the body. Common symptoms include fatigue, headaches, joint pain, joint swelling, and a rash on the cheeks and nose called butterfly rash.
Doctors in your area are studying a medication to see how it may reduce the disease activity of SLE.
You may qualify for the SOAR study if you:
*Are 18 years or older
*Have persistently active SLE
*Have symptoms or signs of your SLE that include rash, and/or joint swelling, and /pain (arthritis) that have not responded to
the SLE treatments you are taking
*Are currently taking prednisone (or equivalent) to treat these symptoms of SLE
Additional requirements apply,
If you qualify and agree to participate, the study treatment and study-related care will be provided to you ate no cost.
To see if you qualify or for additional information, please contact us below.